Pharma in review: trending stories 8/23/19

Aug 23, 2019


Pfizer recalls migraine drug for possible microbial contamination

Pfizer has recalled two lots of migraine drug Relpax.

number2FDA warns Chinese co. for data integrity violations
The agency posted a warning letter to Ningbo Huize Commodity, an OTC drug manufacturer.

number3AbbVie’s Humira follow-up gets FDA nod

 A potential new blockbuster from AbbVie has gotten the go-ahead from the FDA.


FDA rejects potential jet lag treatment

Vanda Pharma announced that it has received a complete response letter from the FDA for Hetlioz.


Celgene wins key FDA ok ahead of BMS merger

The U.S. FDA has approved Celgene's rare bone marrow cancer drug, Inrebic. 


Don't miss your Daily Dose. Get news like this delivered right to your inbox.